A biopharmaceutical company developing antibody radionuclide conjugates for haematological cancers with their lead molecule Betalutin in Phase I and IIb studies.
A biopharmaceutical company developing antibody radionuclide conjugates for haematological cancers with their lead molecule Betalutin in Phase I and IIb studies.